CIBC Private Wealth Group
CYTK icon

CIBC Private Wealth Group’s Cytokinetics CYTK Stock Holding History

CIBC Private Wealth Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$237K Buy
3,723
+239
+7% +$14.9K ﹤0.01% 1122
2025
Q3 		$191K Buy
3,484
+261
+8% +$10.8K ﹤0.01% 1205
2025
Q2 		$106K Buy
3,223
+1,515
+89% +$52.7K ﹤0.01% 1354
2025
Q1 		$59K Buy
1,708
+55
+3% +$2.53K ﹤0.01% 1572
2024
Q4 		$78.3K Buy
1,653
+148
+10% +$7.69K ﹤0.01% 1508
2024
Q3 		$79.5K Buy
1,505
+498
+49% +$27.8K ﹤0.01% 1591
2024
Q2 		$57.1K Buy
+1,007
New +$60.8K ﹤0.01% 1626

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CIBC Private Wealth Group's CYTK Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Cytokinetics (CYTK) stake by 6.9% in Q4 2025, buying an estimated $14.9K and bringing the position to 3,723 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

CIBC Private Wealth Group first reported a position in CYTK in Q2 2024 and has held it in 7 quarters since. 430 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.

  • CIBC Private Wealth Group held 3,723 shares of Cytokinetics worth $237K as of Q4 2025.
  • CIBC Private Wealth Group bought 239 Cytokinetics shares in Q4 2025, an estimated $14.9K.
  • Cytokinetics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1122 holding.
  • CIBC Private Wealth Group first reported a position in Cytokinetics in Q2 2024 and has held it in 7 quarters since.
  • 430 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.